Another possible reason for an EGFR IHC negative tumour responding to the treatment response may be heterogeneous overexpression of EGFR in such cases similar to apparently HER2 negative breast cancer cases showing response to Herceptin treatment [65, 66]. This evidence concerns the gene EGFR and neoplasm.